Chemical
Browse
Active Pharmaceutical Ingredients
Bioactive chemicals
Agrochemicals
Search
Chemical Structure
Explore
Chemical Similarity
Transformation
Browse
Prodrugs
Drug Metabolites
Metabolite Datasets
Biochemical Action
Browse
Target Level (ChEMBL)
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Mechanism of action
Search
Mechanism of action
BLAST against human drug target
BLAST against selected species (UniProt)
Exposure
Browse
Monitoring data
Downloads
Web services
Bulk downloads
About
About EcoDrug+
Citing
Data Sources
Contact Us
Versions and log file
Display Options:
Molecule Type
Mechanism of Action
Route of Adminstration
Status
Therapeutic Indication
Number of compounds:
7959
DEXBROMPHENIRAMINE
(1963)
Small molecule
Unknown
Unknown
Approved
Hypersensitivity
DEXBROMPHENIRAMINE
×
Maximum Phase:
4
First Approval:
1963
UNII:
75T64B71RP
Molecule Type:
Small molecule
Molecular Formula:
C16H19BrN2
Molecular Weight:
319.25
AlogP:
3.93
PSA:
16.13
HBD:
0.0
HBA:
#RotB:
5.0
Source:
FLUOCINOLONE ACETONIDE
(1963)
Small molecule
Glucocorticoid receptor agonist
INTRAVITREAL; OTIC; TOPICAL
Approved
Dermatitis, Atopic; Dermatitis, Seborrheic; Eye Diseases; Hemorrhoids; Infections; Macular Edema; Melanosis; Psoriasis; Skin Diseases; Uveitis
FLUOCINOLONE ACETONIDE
×
Maximum Phase:
4
First Approval:
1963
UNII:
0CD5FD6S2M
Molecule Type:
Small molecule
Molecular Formula:
C24H30F2O6
Molecular Weight:
452.49
AlogP:
2.37
PSA:
93.06
HBD:
2.0
HBA:
#RotB:
2.0
Source:
IDOXURIDINE
(1963)
Small molecule
DNA inhibitor
OPHTHALMIC
Approved
Eye Infections; Virus Diseases
IDOXURIDINE
×
Maximum Phase:
4
First Approval:
1963
UNII:
LGP81V5245
Molecule Type:
Small molecule
Molecular Formula:
C9H11IN2O5
Molecular Weight:
354.1
AlogP:
-1.22
PSA:
104.55
HBD:
3.0
HBA:
#RotB:
2.0
Source:
PRALIDOXIME CHLORIDE
(1964)
Small molecule
Acetylcholinesterase activator
INJECTION; ORAL
Approved
Myasthenia Gravis; Poisoning
PRALIDOXIME CHLORIDE
×
Maximum Phase:
4
First Approval:
1964
UNII:
38X7XS076H
Molecule Type:
Small molecule
Molecular Formula:
C7H9ClN2O
Molecular Weight:
172.61
AlogP:
0.32
PSA:
36.47
HBD:
1.0
HBA:
#RotB:
1.0
Source:
NALIDIXIC ACID
(1964)
Small molecule
Bacterial DNA gyrase inhibitor
ORAL
Approved
Bacterial Infections
NALIDIXIC ACID
×
Maximum Phase:
4
First Approval:
1964
UNII:
3B91HWA56M
Molecule Type:
Small molecule
Molecular Formula:
C12H12N2O3
Molecular Weight:
232.24
AlogP:
1.42
PSA:
72.19
HBD:
1.0
HBA:
#RotB:
2.0
Source:
OXANDROLONE
(1964)
Small molecule
Androgen Receptor agonist
ORAL
Approved
Unknown
OXANDROLONE
×
Maximum Phase:
4
First Approval:
1964
UNII:
7H6TM3CT4L
Molecule Type:
Small molecule
Molecular Formula:
C19H30O3
Molecular Weight:
306.45
AlogP:
3.54
PSA:
46.53
HBD:
1.0
HBA:
#RotB:
0.0
Source:
NORTRIPTYLINE
(1964)
Small molecule
Unknown
Unknown
Metabolites
Depressive Disorder
NORTRIPTYLINE
×
Maximum Phase:
4
First Approval:
1964
UNII:
BL03SY4LXB
Molecule Type:
Small molecule
Molecular Formula:
C19H21N
Molecular Weight:
263.38
AlogP:
3.83
PSA:
12.03
HBD:
1.0
HBA:
#RotB:
3.0
Source:
LINCOMYCIN HYDROCHLORIDE
(1964)
Small molecule
70S ribosome inhibitor
INJECTION; ORAL
Approved
Enterocolitis, Pseudomembranous; Infections
LINCOMYCIN HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1964
UNII:
M6T05Z2B68
Molecule Type:
Small molecule
Molecular Formula:
C18H37ClN2O7S
Molecular Weight:
461.02
AlogP:
-0.86
PSA:
122.49
HBD:
5.0
HBA:
#RotB:
7.0
Source:
MELPHALAN
(1964)
Small molecule
DNA inhibitor
ORAL
Approved
Carcinoma; Multiple Myeloma; Neoplasms
MELPHALAN
×
Maximum Phase:
4
First Approval:
1964
UNII:
Q41OR9510P
Molecule Type:
Small molecule
Molecular Formula:
C13H18Cl2N2O2
Molecular Weight:
305.21
AlogP:
1.93
PSA:
66.56
HBD:
2.0
HBA:
#RotB:
8.0
Source:
LINCOMYCIN
(1964)
Small molecule
Unknown
Unknown
Approved
Bacterial Infections; Multiple Sclerosis
LINCOMYCIN
×
Maximum Phase:
4
First Approval:
1964
UNII:
BOD072YW0F
Molecule Type:
Small molecule
Molecular Formula:
C18H34N2O6S
Molecular Weight:
406.55
AlogP:
-0.86
PSA:
122.49
HBD:
5.0
HBA:
#RotB:
7.0
Source:
ACETOHEXAMIDE
(1964)
Small molecule
Sulfonylurea receptor 1, Kir6.2 blocker
ORAL
Approved
Diabetes Mellitus
ACETOHEXAMIDE
×
Maximum Phase:
4
First Approval:
1964
UNII:
QGC8W08I6I
Molecule Type:
Small molecule
Molecular Formula:
C15H20N2O4S
Molecular Weight:
324.4
AlogP:
2.21
PSA:
92.34
HBD:
2.0
HBA:
#RotB:
4.0
Source:
PRALIDOXIME
(1964)
Small molecule
Unknown
Unknown
Approved
Unknown
PRALIDOXIME
×
Maximum Phase:
4
First Approval:
1964
UNII:
YV274KB8PY
Molecule Type:
Small molecule
Molecular Formula:
C7H9N2O+
Molecular Weight:
137.16
AlogP:
0.32
PSA:
36.47
HBD:
1.0
HBA:
#RotB:
1.0
Source:
AMINOCAPROIC ACID
(1964)
Small molecule
Plasminogen inhibitor
INJECTION; ORAL
Approved
Hemorrhage
AMINOCAPROIC ACID
×
Maximum Phase:
4
First Approval:
1964
UNII:
U6F3787206
Molecule Type:
Small molecule
Molecular Formula:
C6H13NO2
Molecular Weight:
131.18
AlogP:
0.59
PSA:
63.32
HBD:
2.0
HBA:
#RotB:
5.0
Source:
CYCLOSERINE
(1964)
Small molecule
Alanine racemase inhibitor
ORAL
Approved
Tuberculosis
CYCLOSERINE
×
Maximum Phase:
4
First Approval:
1964
UNII:
95IK5KI84Z
Molecule Type:
Small molecule
Molecular Formula:
C3H6N2O2
Molecular Weight:
102.09
AlogP:
-1.62
PSA:
64.35
HBD:
2.0
HBA:
#RotB:
0.0
Source:
NOVOBIOCIN SODIUM
(1964)
Small molecule
DNA gyrase inhibitor
ORAL
Approved
Unknown
NOVOBIOCIN SODIUM
×
Maximum Phase:
4
First Approval:
1964
UNII:
Q9S9NQ5YIY
Molecule Type:
Small molecule
Molecular Formula:
C31H35N2NaO11
Molecular Weight:
634.61
AlogP:
3.63
PSA:
200.01
HBD:
5.0
HBA:
#RotB:
8.0
Source:
DESIPRAMINE HYDROCHLORIDE
(1964)
Small molecule
Norepinephrine transporter inhibitor
ORAL
Approved
Depression
DESIPRAMINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1964
UNII:
1Y58DO4MY1
Molecule Type:
Small molecule
Molecular Formula:
C18H23ClN2
Molecular Weight:
302.85
AlogP:
3.53
PSA:
15.27
HBD:
1.0
HBA:
#RotB:
4.0
Source:
ERYTHROMYCIN
(1964)
Small molecule
Bacterial 70S ribosome inhibitor
FOR RX COMPOUNDING; OPHTHALMIC; ORAL; TOPICAL
Approved
Acne Vulgaris; Bacterial Infections; Eye Infections
ERYTHROMYCIN
×
Maximum Phase:
4
First Approval:
1964
UNII:
63937KV33D
Molecule Type:
Small molecule
Molecular Formula:
C37H67NO13
Molecular Weight:
733.94
AlogP:
1.79
PSA:
193.91
HBD:
5.0
HBA:
#RotB:
7.0
Source:
TRIAMTERENE
(1964)
Small molecule
Amiloride-sensitive sodium channel, ENaC blocker
ORAL
Approved
Cardiovascular Diseases; Edema; Heart Failure; Hyperaldosteronism; Hypertension; Liver Cirrhosis; Nephrotic Syndrome; Toxemia
TRIAMTERENE
×
Maximum Phase:
4
First Approval:
1964
UNII:
WS821Z52LQ
Molecule Type:
Small molecule
Molecular Formula:
C12H11N7
Molecular Weight:
253.27
AlogP:
0.83
PSA:
129.62
HBD:
3.0
HBA:
#RotB:
1.0
Source:
NOVOBIOCIN
(1964)
Small molecule
Unknown
Unknown
Approved
Unknown
NOVOBIOCIN
×
Maximum Phase:
4
First Approval:
1964
UNII:
17EC19951N
Molecule Type:
Small molecule
Molecular Formula:
C31H36N2O11
Molecular Weight:
612.63
AlogP:
3.63
PSA:
200.01
HBD:
5.0
HBA:
#RotB:
8.0
Source:
DESIPRAMINE
(1964)
Small molecule
Unknown
Unknown
Approved
Depressive Disorder
DESIPRAMINE
×
Maximum Phase:
4
First Approval:
1964
UNII:
TG537D343B
Molecule Type:
Small molecule
Molecular Formula:
C18H22N2
Molecular Weight:
266.39
AlogP:
3.53
PSA:
15.27
HBD:
1.0
HBA:
#RotB:
4.0
Source:
AMPHOTERICIN B
(1964)
Small molecule
Ergosterol sequestering agent
INJECTION; ORAL; TOPICAL
Approved
Aspergillosis; Candidiasis; Cryptococcosis; Histoplasmosis; Infections; Leishmaniasis, Visceral; Meningitis, Cryptococcal; Mucormycosis; Mycoses; Sporotrichosis; Zygomycosis
AMPHOTERICIN B
×
Maximum Phase:
4
First Approval:
1964
UNII:
7XU7A7DROE
Molecule Type:
Small molecule
Molecular Formula:
C47H73NO17
Molecular Weight:
924.09
AlogP:
0.71
PSA:
319.61
HBD:
12.0
HBA:
#RotB:
3.0
Source:
ETHYLESTRENOL
(1964)
Small molecule
Androgen Receptor agonist
ORAL
Approved
Unknown
ETHYLESTRENOL
×
Maximum Phase:
4
First Approval:
1964
UNII:
ADC79EK5Q8
Molecule Type:
Small molecule
Molecular Formula:
C20H32O
Molecular Weight:
288.48
AlogP:
5.09
PSA:
20.23
HBD:
1.0
HBA:
#RotB:
1.0
Source:
NYSTATIN
(1964)
Small molecule
Ergosterol sequestering agent
ORAL; TOPICAL; VAGINAL
Approved
Candidiasis; Infections
NYSTATIN
×
Maximum Phase:
4
First Approval:
1964
UNII:
W1LX4T91WI
Molecule Type:
Small molecule
Molecular Formula:
C47H75NO17
Molecular Weight:
926.11
AlogP:
0.94
PSA:
319.61
HBD:
12.0
HBA:
#RotB:
3.0
Source:
ERYTHROMYCIN STEARATE
(1964)
Small molecule
Bacterial 70S ribosome inhibitor
ORAL
Approved
Unknown
ERYTHROMYCIN STEARATE
×
Maximum Phase:
4
First Approval:
1964
UNII:
LXW024X05M
Molecule Type:
Small molecule
Molecular Formula:
C55H103NO15
Molecular Weight:
1018.42
AlogP:
1.79
PSA:
193.91
HBD:
5.0
HBA:
#RotB:
7.0
Source:
VANCOMYCIN
(1964)
Small molecule
Peptidoglycan inhibitor
Unknown
Approved
Bacterial Infections; Diarrhea; Endocarditis; Enterocolitis; Eye Infections; Respiratory Tract Infections; Sepsis; Skin Diseases
VANCOMYCIN
×
Maximum Phase:
4
First Approval:
1964
UNII:
6Q205EH1VU
Molecule Type:
Small molecule
Molecular Formula:
C66H75Cl2N9O24
Molecular Weight:
1449.27
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
VANCOMYCIN HYDROCHLORIDE
(1964)
Small molecule
Peptidoglycan inhibitor
Unknown
Approved
Endocarditis; Infections
VANCOMYCIN HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1964
UNII:
71WO621TJD
Molecule Type:
Small molecule
Molecular Formula:
C66H76Cl3N9O24
Molecular Weight:
1485.73
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
OXYTETRACYCLINE
(1964)
Small molecule
Bacterial 70S ribosome inhibitor
ORAL
Approved
Bacterial Infections; Eye Infections
OXYTETRACYCLINE
×
Maximum Phase:
4
First Approval:
1964
UNII:
SLF0D9077S
Molecule Type:
Small molecule
Molecular Formula:
C22H24N2O9
Molecular Weight:
460.44
AlogP:
-1.24
PSA:
201.85
HBD:
7.0
HBA:
#RotB:
2.0
Source:
NORTRIPTYLINE HYDROCHLORIDE
(1964)
Small molecule
Norepinephrine transporter inhibitor
ORAL
Approved
Depression
NORTRIPTYLINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1964
UNII:
00FN6IH15D
Molecule Type:
Small molecule
Molecular Formula:
C19H22ClN
Molecular Weight:
299.85
AlogP:
3.83
PSA:
12.03
HBD:
1.0
HBA:
#RotB:
3.0
Source:
OXYTETRACYCLINE HYDROCHLORIDE
(1964)
Small molecule
Bacterial 70S ribosome inhibitor
INJECTION; ORAL
Approved
Unknown
OXYTETRACYCLINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1964
UNII:
4U7K4N52ZM
Molecule Type:
Small molecule
Molecular Formula:
C22H25ClN2O9
Molecular Weight:
496.9
AlogP:
-1.24
PSA:
201.85
HBD:
7.0
HBA:
#RotB:
2.0
Source:
TRIOXSALEN
(1964)
Small molecule
DNA inhibitor
ORAL
Approved
Psoriasis
TRIOXSALEN
×
Maximum Phase:
4
First Approval:
1964
UNII:
Y6UY8OV51T
Molecule Type:
Small molecule
Molecular Formula:
C14H12O3
Molecular Weight:
228.25
AlogP:
3.46
PSA:
43.35
HBD:
0.0
HBA:
#RotB:
0.0
Source:
ERYTHROMYCIN LACTOBIONATE
(1964)
Small molecule
Bacterial 70S ribosome inhibitor
INJECTION
Approved
Unknown
ERYTHROMYCIN LACTOBIONATE
×
Maximum Phase:
4
First Approval:
1964
UNII:
33H58I7GLQ
Molecule Type:
Small molecule
Molecular Formula:
C49H89NO25
Molecular Weight:
1092.23
AlogP:
1.79
PSA:
193.91
HBD:
5.0
HBA:
#RotB:
7.0
Source:
NAFCILLIN SODIUM
(1965)
Small molecule
Penicillin-binding protein inhibitor
INJECTION; ORAL
Approved
Infections
NAFCILLIN SODIUM
×
Maximum Phase:
4
First Approval:
1965
UNII:
49G3001BCK
Molecule Type:
Small molecule
Molecular Formula:
C21H23N2NaO6S
Molecular Weight:
454.48
AlogP:
2.48
PSA:
95.94
HBD:
2.0
HBA:
#RotB:
5.0
Source:
PRILOCAINE HYDROCHLORIDE
(1965)
Small molecule
Sodium channel alpha subunit blocker
INJECTION
Approved
Unknown
PRILOCAINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1965
UNII:
MJW015BAPH
Molecule Type:
Small molecule
Molecular Formula:
C13H21ClN2O
Molecular Weight:
256.78
AlogP:
2.32
PSA:
41.13
HBD:
2.0
HBA:
#RotB:
5.0
Source:
EPINEPHRINE BITARTRATE
(1965)
Small molecule
Adrenergic receptor agonist
INHALATION
Approved
Pain
EPINEPHRINE BITARTRATE
×
Maximum Phase:
4
First Approval:
1965
UNII:
30Q7KI53AK
Molecule Type:
Small molecule
Molecular Formula:
C13H19NO9
Molecular Weight:
333.29
AlogP:
0.35
PSA:
72.72
HBD:
4.0
HBA:
#RotB:
3.0
Source:
CHLORPHENESIN CARBAMATE
(1965)
Small molecule
Unknown
ORAL
Approved
Unknown
CHLORPHENESIN CARBAMATE
×
Maximum Phase:
4
First Approval:
1965
UNII:
HQC4WI89YG
Molecule Type:
Small molecule
Molecular Formula:
C10H12ClNO4
Molecular Weight:
245.66
AlogP:
1.17
PSA:
81.78
HBD:
2.0
HBA:
#RotB:
5.0
Source:
VINBLASTINE SULFATE
(1965)
Small molecule
Tubulin inhibitor
INJECTION
Approved
Communicable Diseases; Hodgkin Disease; Lymphoma; Lymphoma, Large B-Cell, Diffuse
VINBLASTINE SULFATE
×
Maximum Phase:
4
First Approval:
1965
UNII:
N00W22YO2B
Molecule Type:
Small molecule
Molecular Formula:
C46H60N4O13S
Molecular Weight:
909.07
AlogP:
3.99
PSA:
154.1
HBD:
3.0
HBA:
#RotB:
7.0
Source:
1
2
…
10
11
12
13
14
15
16
…
221
222
Next »
Download Option
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA